COLLEEN SUTER: Open Payments
NPI 1538153119 · HORSHAM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 10 payments from 7 companies in 2025. Trend: 2023 $302 · 2024 $472 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $151 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Boston Scientific Corporation | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: Barostim Neo System, WAINUA, WATCHMAN FLX, CAMZYOS, LEQVIO, NEXLETOL, REPATHA.
Industry payments across PA — which companies pay providers there.
